LDL-c targets in the ESC/EAS dyslipidaemia guidelines in a nutshell10' education - Oct. 4, 2019 - Prof. Brian Ference, MD - Cambridge, UK
Video navigation menu
- Foundation of the new guidelines 0:27
- Recommendations for CVD risk estimation 2:14
- Recommendations for treatment goals for LDL-c 6:11
This lecture by prof. Brian Ference was part of an accredited symposium "LDL-c guidance on the novel ESC/EAS dyslipidaemia guidelines: Expert discussions on practical implications" held during ESC 2019 in Paris, France.
Prof. Brian A. Ference, M.D, Professor and Director of Research in Translational Therapeutics, Executive Director, Centre for Naturally Randomized Trials, University of Cambridge, United Kingdom
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
Funding for this educational program was provided by an unrestricted educational grant from Amgen, Sanofi-Regeneron and Pfizer - Upjohn.